Estonia - estoński - Ravimiamet

actavis group ptc ehf. - valsartaan+hüdroklorotiasiid - õhukese polümeerikattega tablett - 160mg+25mg 7tk; 160mg+25mg 14tk; 160mg+25mg 100tk; 160mg+25mg 98tk; 160mg+25mg 28tk

Estonia - estoński - Ravimiamet

zentiva k.s. - telmisartaan+hüdroklorotiasiid - tablett - 80mg+12,5mg 30tk; 80mg+12,5mg 14tk; 80mg+12,5mg 28tk; 80mg+12,5mg 90tk; 80mg+12,5mg 84tk

Estonia - estoński - Ravimiamet

actavis group ptc ehf. - kandesartaan+hüdroklorotiasiid - tablett - 8mg+12,5mg 90tk; 8mg+12,5mg 56tk; 8mg+12,5mg 14tk; 8mg+12,5mg 70tk; 8mg+12,5mg 7tk; 8mg+12,5mg 98tk; 8mg+12,5mg 30tk

Estonia - estoński - Ravimiamet

doc generici s.r.l. - olmesartaanmedoksomiil+hüdroklorotiasiid - õhukese polümeerikattega tablett - 20mg+25mg 28tk; 20mg+25mg 100tk; 20mg+25mg 98tk; 20mg+25mg 90tk; 20mg+25mg 30tk; 20mg+25mg 14tk

Estonia - estoński - Ravimiamet

actavis group ptc ehf. - kandesartaan+hüdroklorotiasiid - tablett - 32mg+12,5mg 30tk; 32mg+12,5mg 10tk; 32mg+12,5mg 250tk; 32mg+12,5mg 50tk; 32mg+12,5mg 90tk; 32mg+12,5mg 20tk; 32mg+12,5mg 28tk; 32mg+12,5mg 56tk; 32mg+12,5mg 14tk; 32mg+12,5mg 7tk; 32mg+12,5mg 98tk

Estonia - estoński - Ravimiamet

actavis nordic a/s - ramipriil+hüdroklorotiasiid - tablett - 5mg+25mg 50tk; 5mg+25mg 14tk; 5mg+25mg 42tk; 5mg+25mg 98tk; 5mg+25mg 20tk; 5mg+25mg 30tk

Estonia - estoński - Ravimiamet

teva pharma b.v. - kandesartaan+hüdroklorotiasiid - tablett - 8mg+12,5mg 100tk; 8mg+12,5mg 50tk; 8mg+12,5mg 90tk; 8mg+12,5mg 15tk; 8mg+12,5mg 20tk; 8mg+12,5mg 98tk; 8mg+12,5mg 10tk; 8mg+12,5mg 60tk

Estonia - estoński - Ravimiamet

doc generici s.r.l. - olmesartaanmedoksomiil+hüdroklorotiasiid - õhukese polümeerikattega tablett - 40mg+12,5mg 98tk; 40mg+12,5mg 30tk; 40mg+12,5mg 90tk; 40mg+12,5mg 14tk

Unia Europejska - estoński - EMA (European Medicines Agency)

gedeon richter plc. - follitropiin alfa - anovulatsioon - suguhormoonid ja genitaalsüsteemi, - in adult women:anovulation (including polycystic ovarian disease, pcod) in women who have been unresponsive to treatment with clomiphene citrate;stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (art) such as in vitro fertilisation (ivf), gamete intra-fallopian transfer (gift) and zygote intra-fallopian transfer (zift);follitropin alfa in association with a luteinising hormone (lh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. kliinilistes uuringutes on nendel patsientidel olid määratletud on endogeensed seerumi lh tase < 1. 2 rÜ / l. in adult men:follitropin alfa is indicated for the stimulation of spermatogenesis in men who have congenital or acquired hypogonadotrophic hypogonadism with concomitant human chorionic gonadotrophin (hcg) therapy.

Unia Europejska - estoński - EMA (European Medicines Agency)

n.v. organon - korifollitropiin alfa - reproductive techniques, assisted; ovulation induction; investigative techniques - suguhormoonid ja genitaalsüsteemi, - controlled ovarian stimulation (cos) in combination with a gnrh antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (art) program. elonva is indicated for the treatment of adolescent males (14 to less than 18 years and older) with hypogonadotropic hypogonadism, in combination with human chorionic gonadotropin (hcg).